Türk Biyokimya Dergisi (Jun 2024)

Joint effects of PPARG-C161T (rs3856806) polymorphism and cardiovascular risk factors on restenosis risk after coronary stent implantation

  • Javadova Zahra,
  • Yanar Fatih,
  • Aslan Ezgi Irmak,
  • Ozkara Gulcin,
  • Malikova Fidan,
  • Kilicarslan Onur,
  • Ser Ozgur Selim,
  • Yildiz Ahmet,
  • Kucukhuseyin Ozlem,
  • Ozturk Oguz,
  • Yilmaz Aydogan Hulya

DOI
https://doi.org/10.1515/tjb-2024-0021
Journal volume & issue
Vol. 49, no. 4
pp. 568 – 577

Abstract

Read online

The peroxisome proliferator-activated receptor gamma (PPARG) C161T polymorphism (rs3856806) may be a risk factor for in-stent restenosis (ISR) due to its known associations with type 2 diabetes (T2DM), obesity, and coronary artery disease (CAD). This study aims to investigate the relationship between PPARG-C161T polymorphism and the risk of ISR, considering clinical features.

Keywords